Literature DB >> 22504166

A novel acute phase reactant, serum amyloid A-like 1, from Oplegnathus fasciatus: genomic and molecular characterization and transcriptional expression analysis.

Kasthuri Saranya Revathy1, Navaneethaiyer Umasuthan, Ilson Whang, Youngdeuk Lee, Sukkyoung Lee, Myung-Joo Oh, Sung-Ju Jung, Cheol Young Choi, Choul-Ji Park, Hae-Chul Park, Jehee Lee.   

Abstract

Acute phase response is a significant component of innate immunity, playing a vital role in the signaling processes and elimination of invading pathogens. Acute phase proteins are synthesized in liver and secreted into the blood for transportation to an infection site, where the defense function is exerted. Serum amyloid A (SAA) and C-reactive proteins are the major positive acute phase proteins. In this study, we have identified and characterized a novel SAA related gene from rock bream (Oplegnathus fasciatus), designated OfSAAL1. Genomic characterization revealed the presence of 13 exons and 12 introns, similar to SAAL1 in zebrafish. Multiple protein sequence alignment revealed high conservation with other SAAL1 homologues. Phylogenetic analysis showed that OfSAAL1 clustered with another fish homologue, and pairwise alignment revealed highest identity and similarity at the amino acid level with zebrafish SAAL1. Promoter region analysis revealed the presence of immunologically significant transcription factor binding sites. Tissue distribution profiling to indicate physiological relevance showed the highest levels occur in blood, followed by liver, suggesting a positive immune role in rock bream. Transcriptional analysis by reverse transcription polymerase chain reaction to understand OfSAAL1 responsiveness to immune challenge with poly I:C, Edwardsiella tarda, Streptococcus iniae and rock bream iridovirus, revealed a significant level of elevation from 12h to 48 h post-infection in blood, spleen, head kidney, and liver. To our knowledge, OfSAAL1 is the first characterized SAAL1 homologue from teleosts. We anticipate that its identification will prove inspiring for further studies of SAAL1 homologues as biomarkers of the acute phase response.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504166     DOI: 10.1016/j.dci.2012.03.014

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  5 in total

1.  Molecular characterization and expressional affirmation of the beta proteasome subunit cluster in rock bream immune defense.

Authors:  Saranya Revathy Kasthuri; Navaneethaiyer Umasuthan; Ilson Whang; Bong-Soo Lim; Hyung-Bok Jung; Myung-Joo Oh; Sung-Ju Jung; Sang-Yeob Yeo; Sung Yeon Kim; Jehee Lee
Journal:  Mol Biol Rep       Date:  2014-05-28       Impact factor: 2.316

2.  Antimicrobial and Immunoregulatory Activities of TS40, a Derived Peptide of a TFPI-2 Homologue from Black Rockfish (Sebastes schlegelii).

Authors:  Hongmei Liu; Guanghua Wang; Dongfang Hao; Changbiao Wang; Min Zhang
Journal:  Mar Drugs       Date:  2022-05-26       Impact factor: 6.085

3.  Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1.

Authors:  Sara Abouelasrar Salama; Mirre De Bondt; Mieke De Buck; Nele Berghmans; Paul Proost; Vivian Louise Soares Oliveira; Flavio A Amaral; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Front Immunol       Date:  2020-05-14       Impact factor: 7.561

4.  Serum amyloid A is a positive acute phase protein in Russian sturgeon challenged with Aeromonas hydrophila.

Authors:  Mauricio Castellano; Valeria Silva-Álvarez; Marcio Aversa-Marnai; María Lamas-Bervejillo; Ignacio Quartiani; Alejandro Perretta; Andrea Villarino; Ana María Ferreira
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

5.  SAAL1, a novel oncogene, is associated with prognosis and immunotherapy in multiple types of cancer.

Authors:  Wei Yang; Bing Han; Yecheng Chen; Feng Geng
Journal:  Aging (Albany NY)       Date:  2022-08-13       Impact factor: 5.955

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.